How much is Silicon Therapeutics worth in 2026?

Silicon Therapeutics has a current valuation of N/A based on their Buyout/LBO (Add-on)† round and secondary market data.

How much funding has Silicon Therapeutics raised?

Silicon Therapeutics has raised N/A in total funding across 1 funding rounds.

Silicon Therapeutics

Drug Discovery

Silicon Therapeutics valuation and funding history | Last updated: February 26, 2021 | 1 funding rounds

Current Valuation

N/A

As of February 26, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Buyout/LBO (Add-on)†

$450.0M

Last Funding

Feb 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 26, 2021	Buyout/LBO (Add-on)†	$450.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Silicon Therapeutics is currently valued at N/A as of February 26, 2021.

Track Silicon Therapeutics Valuation Updates

Get notified when Silicon Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Silicon Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Silicon Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Silicon Therapeutics Worth in 2026?

Silicon Therapeutics is a leading private company in the Drug Discovery sector. Track Silicon Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Silicon Therapeutics Valuation is Determined

Private company valuations like Silicon Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.